Asia Fresh News

Asia Fresh Stories

Archive for May 16th, 2016

Phenomenome Discoveries Announces the Successful Validation of OvAware™, a simple blood test for the Early Detection of Ovarian Cancer

leave a comment »

-Early detection seen as key to reducing mortality

SASKATOON, Saskatchewan /PRNewswire/ — Using its proprietary metabolomics technology, Phenomenome Discoveries Inc. had previously discovered that specific metabolic abnormalities were present in the blood of women suffering from ovarian cancer.  The company has subsequently developed a simple test (OvAware™) that can be performed on a single drop of blood.  The performance of the test has now been verified in two large studies – one in Japan (99 controls and 112 ovarian cancer patients) led by Dr. Fumio Nomura, MD,Chiba, Japan and one in Canada (1041 controls and 325 ovarian cancer patients) led by Dr. Walter Gotlieb, MD, PhD, Montreal, Canada.  In both studies, the blood test was able to detect ovarian cancer with 97% accuracy.  The results of these studies will be presented by Dr. Dayan Goodenowe, Founder, President and CEO, Phenomenome Discoveries at the Cancer Diagnostics Conference and Expo in Rome, Italy on June 13th, 2016.

“Ovarian cancer is the most lethal among the pelvic cancers. The majority of the patients are diagnosed at an advanced stage with metastatic spread beyond the pelvis. This is mainly due to a lack of effective ways for surveillance and early diagnosis of this malignancy,”

  • Dr. Fumio Nomura, Professor and Director, Department of Molecular Diagnosis and Division of Laboratory Medicine, Clinical Genetics and Proteomics Organization: Graduate School of Medicine, Chiba University and Chiba University Hospital, Chiba, Japan

“Despite major progress in cytotoxic treatments, outcome of high grade serous ovarian cancer remains poor, mainly due to the absence of early detection with our present tools.”

  • Dr. Walter Gotlieb, MD, PhD, Director, Gynecologic Oncology and Colposcopy at Sir Mortimer B. Davis, Jewish General Hospital, Montreal, Canada

The early detection of ovarian cancer may be much closer to reality today.  Phenomenome Discoveries’ cancer diagnostics, which also includes Cologic® for colon cancer and PanaSee™ for pancreatic cancer, are based upon its unique prodrome detection technology, which identifies persons with specific metabolic abnormalities that precede the formation of specific cancers.  This technology differs from traditional pathology-based cancer detection technologies in that persons who do not have these metabolic abnormalities are protected from getting the specific cancer identified by the test whereas persons exhibiting the metabolic abnormality have an elevated risk of the cancer.  This technology is particularly valuable for the management of aggressive cancers, like ovarian cancer, which are difficult to detect at an early stage and which prophylactic prevention options are available.

“It is well recognized that physical bimanual examination, gynecological ultrasound imaging and the available tumor markers are not sensitive enough for early detection of ovarian cancers. Therefore, we desperately need sensitive and practical serum marker that can designate the subjects having a high risk for ovarian cancer.” Dr. Nomura

“Being able to detect ovarian cancer early or being able to accurately identify high risk subjects requiring increased monitoring and prevention by risk reducing surgery is critical in order to reduce mortality from this ‘silent killer’.  A simple blood test would go a long way to achieve this.” Dr. Gotlieb

According to the American Cancer Society, “when ovarian cancer is found early at a localized stage, about 94% of patients live longer than 5 years after diagnosis.” Phenomenome Discoveries expects to apply to Health Canada for approval of the test later this year, which could make it available in 2017.

The results of the studies and more information about the science behind the test can be found at the company’s website:

Phenomenome Discoveries is undergoing restructuring via receivership proceedings which will ultimately result in a transfer of ownership of its proprietary technologies.

For further information – Jamie Engen, +1-604-417-7375

Source: Phenomenome Discoveries Inc.

Written by asiafreshnews

May 16, 2016 at 3:59 pm

Posted in Uncategorized

Alice Dellal Announced as Official Martini(R) Race Photographer for 2016 Formula One(TM) Season

leave a comment »

HAMILTON, Bermuda /PRNewswire/ — MARTINI®, one of the world’s most iconic Italian brands and the world’s leading vermouth and best-selling Italian sparkling wine, kicked off the European Formula One™ season by announcing model Alice Dellal as their 2016 MARTINI Race Photographer at an exclusive Terrazza MARTINI event in Barcelona celebrating the Spanish Grand Prix.

(Photo: )
(Photo: )

Dellal has been commissioned to capture images of the MARTINI lifestyle on and off the track as she discovers the unique identity, style and culture of each race city. Dellal will also feature in creative collaborations with Williams MARTINI Racing drivers Felipe Massa and Valtteri Bottas. Following her work in Barcelona, she is scheduled to make appearances during race weekends in Milan, Singapore, Mexico City and Sao Paulo.

British/Brazilian supermodel and style icon, Dellal is a regular feature on covers around the world and is an ambassador for Chanel. Alice’s skills and passion as a photographer have grown simultaneously with her working with internationally renowned photographers.

“Not only is it cool, it’s really exciting to be part of the MARTINI project which is about showcasing city style and culture against the backdrop of one of the world’s sexiest sports,” explained Dellal. “Images have the power to introduce a whole new audience to racing and to one of the world’s most iconic Italian brands, and I look forward to portraying that in my photos.”

Barcelona’s luxurious Marina Port Vell was transformed as the Terrazza MARTINI played host to over 500 VIP guests including Dellal, Williams MARTINI Racing drivers Felipe Massa and Valtteri Bottas, Deputy Team Principal and Commercial Director Claire Williams, chef Jamie Oliver and Spanish actress Eva Gonzales for the exclusive kick-off party on Thursday 12 May, 2015.

Terrazza MARTINI Barcelona is located at Marina Port Vell and will be open to the public from Friday 13-15 May, 2016. Entry is free and guests will enjoy music performances from Primavera Sound and the best modern aperitivo menu created by world-renowned chef Albert Adrià and his team from La Cala.


The MARTINI brand’s longstanding relationship with motorsport and rich history of both sponsorship and participation in worldwide sporting events began in 1968 with the creation of MARTINI Racing™. This bold and ambitious move resulted in a pioneering sponsorship program that saw MARTINI become one of the first-ever non-motorsport entrants to sponsor a racing team.

MARTINI Racing continued to evolve throughout the 1970s, and it was during this period that the distinctive blue and red livery of MARTINI Racing was created. A pioneering design that emulated the team’s speed and style, the MARTINI livery was a consistent presence throughout the heyday of MARTINI Racing between 1971 and 1996.

In 1972, MARTINI made its first foray into Formula One™, partnering with Tecno™ for a one-year deal, and then returned in 1975 as a partner of the Brabham™ team, a partnership that continued for three years. From 2006 – 2008, MARTINI was an official partner of Scuderia Ferrari™, the most prestigious and successful team in the history of the FIA Formula One World Championship™.

With the brand’s return to Formula One™ in 2014, a new generation is discovering the gioia di vivere (the Italian “joy of living”) that MARTINI brings to racing.


One of the most iconic brands in the world, MARTINI® is the leading name in Italian winemaking and a purveyor of the highest quality aromatized and sparkling wines. The award-winning, vibrant and bittersweet taste of the MARTINI range is the result of secret blends of more than 40 botanicals sourced from the finest locations across the globe. The MARTINI portfolio includes: MARTINI Bianco, MARTINI Rosato, MARTINI Rosso, MARTINI Extra Dry, MARTINI Asti, MARTINI Moscato d’Asti, MARTINI Prosecco, MARTINI Rosé, MARTINI Brut and MARTINI Royale. Created in 1863 in Turin, Italy, the MARTINI brand is part of the portfolio of Bacardi Limited, headquartered in Hamilton, Bermuda, and continues to be the market leader of the category. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited.

Be responsible. Never drink and drive.

MARTINI, MARTINI Racing, the ball and bar logo and the MARTINI Racing stripes are trademarks.

For more information, please visit and

Related Links:

Written by asiafreshnews

May 16, 2016 at 3:52 pm

Posted in Uncategorized

Chinese Business Leaders Gaining Direct Reporting Line To CEOs of Global Multinationals

leave a comment »

-Heidrick & Struggles Survey Shows Growing Strategic Importance of Chinese Operations

HONG KONG /PRNewswire/ — According to a recent study conducted by Heidrick & Struggles (Nasdaq: HSII), a premier provider of executive search, leadership consulting and culture shaping, multinational corporations increasingly are creating direct reporting lines for their Chinese operations leader to the CEO or board.

Full Report Link – “Who do China CEOs report to?”

Photo –
Logo –

Most senior executives who oversee China operations still report to APAC regional leaders. But as China operations have contributed an increased share of global revenues and profits, as well as R&D and supply chain, these senior executives increasingly are gaining a more visible and direct relationship with global leadership, including the board and CEO. In some cases this is structural with China operations reporting directly to the CEO, a member of the C-suite or an operating board.

“As China continues to emerge as an economic force, aligning global strategies with China’s 5-year plan has become increasingly important for multinationals,” said Steve Mullinjer, Regional Leader of Heidrick & Struggles,Asia Pacific.

To examine the various reporting line models employed by multinationals and how well these function, Heidrick & Struggles’ Industrial Practice surveyed 100 senior executives in the region who oversee their organization’s operations in China. More than 90% of the respondents were from U.S., European or Asian MNCs headquartered outside China.

“There has been ongoing discussion on how to structure the reporting line between regional headquarters and global headquarters, and some companies have experimented through trial and error. Our research shows that the most common reasons for lack of communication between China operations and global headquarters are cost, and insufficient organizational efficiency,” said Seth Peterson, Partner, Industrial Practice, Heidrick & Struggles.

Key highlights of the study include:

  • The strategic importance of the China market: Close to 60% of respondents said China contributes more than 40% of their Asia Pacific revenue. Nearly 40% reported that China revenues represent 10-30% of their company’s total global earnings. More than 40% of respondents say their company’s China leader sits on the global executive committee or its equivalent, underlining the strategic importance of the China market to the overall business.
  • Who do China Business Leaders Report to? Close to 30% of respondents said their company’s China boss reports directly to global leadership (either the CEO or the global head of a business unit). Half of China heads report to the head of Asia/APAC; 26% of the China leadership surveyed also oversee Asia/APAC operations. Nearly half of respondents said that MNCs do not give their China heads oversight of operations in theAsia/APAC region to avoid diluting the focus of the company’s China leadership.
  • Reporting structures unlikely to change: Some 44% of respondents said their reporting structures had been in place from the start of their company’s involvement in China; 69% said it was unlikely these would be changed in the coming two to three years. Of those surveyed, 17% anticipate changes in their company’s reporting lines within the next two or three years; 29% are not satisfied with their company’s existing structure.

“Companies are often hesitant to make changes to the current structure because they want to avoid duplicating costs, such as costs in their finance and product design departments,” said Peterson.

“Others believe that China revenues have not yet reached a sufficient scale to justify such independent status in the next few years. It is worth noting that some respondents feel their global headquarters do not have sufficient understanding of the China market to add value through direct input,” said Peterson.

About Heidrick & Struggles:
Heidrick & Struggles (NASDAQ: HSII) serves the executive talent and leadership needs of the world’s top organizations as a premier provider of leadership consulting, culture-shaping and senior-level executive search services. Heidrick & Struggles pioneered the profession of executive search more than 60 years ago. Today, the firm serves as a trusted advisor, providing integrated leadership solutions and helping its clients change the world, one leadership team at a time,

H&S Media Contact:
Karen Lau: +852 2103 9329,

Source: Heidrick & Struggles

Related stocks: NASDAQ-NMS:HSII

Related Links:

Written by asiafreshnews

May 16, 2016 at 3:34 pm

Posted in Uncategorized

Biosensors Announces Strategic Agreement With Cardinal Health

leave a comment »

SINGAPORE /PRNewswire/ — Biosensors International Group, Ltd. (“Biosensors” or the “Company“), a developer, manufacturer and marketer of innovative medical devices, today announced that it has entered into a strategic distribution agreement with Cardinal Health.

Through this distribution agreement, Biosensors will significantly increase the market coverage and penetration of its leading family of Drug Eluting Stents (DES) which include the innovative BioFreedom™ polymer-free drug coated stent (DCS) clinically proven to be effective in the treatment of High Bleeding Risk (HBR) patients; the market-proven BioMatrix NeoFlex™ and the recently introduced BioMatrix Alpha™, a cobalt chromium DES with an abluminal bio-absorbable coating and the proprietary BA-9 Biolimus™ drug; and Chroma™, a cobalt-chromium bare metal stent (BMS).

The agreement will initially enable Cordis, Cardinal Health’s interventional vascular business, to sell Biosensors family of DES in various European countries, Australia and New Zealand. Over time, Biosensors and Cardinal Health will partner to further leverage their respective distribution capabilities in select regions.

“The agreement between Biosensors and Cardinal Health is an important milestone in our continuing strategy to deepen our market penetration and expand as well as diversify our product offering,” said Jose (Pepe) Calle, Group CEO of Biosensors. “By working together we will be able to leverage our joint capabilities in delivering world-class breakthrough products including BioFreedom™, as well as maximizing the increased market coverage and geographical footprint of the Biosensors and Cordis franchises.”

Last year, Biosensors announced the exciting results of the LEADERS FREE clinical trial which confirmed the safety and efficacy of BioFreedom™ in one of the largest ever double-blind, randomized, clinical trials involving a DES. The data, which were published in the New England Journal of Medicine as the world’s first prospective, double-blind, randomized clinical trial focusing on patients at high bleeding risk, demonstrated superior safety and efficacy for BioFreedom™ as compared to an uncoated BMS in patients who could tolerate only one month of dual anti-platelet therapy (DAPT)3.The LEADERS FREE trial included 2,466 patients across 68 sites in 20 countries inEurope, Asia, Australia and Canada and used the shortest course of DAPT ever used with an active stent.

“I am excited about the potential of the partnership,” said Mr. Calle. “With our superior technologies, strong relationships with Physicians and Medical Practitioners as well as our positive partnership with the Healthcare community around the world I am confident that Biosensors is continuing to strengthen its position in the global cardiovascular care market.”

Main Contact
David Chin
Tel: (65) 6213 5777

About Biosensors International Group, Ltd.

Biosensors International Group, Ltd. develops, manufactures and markets innovative medical devices, aiming to improve patients’ lives through pioneering medical technology that pushes forward the boundaries of innovation. Founded in 1990, we are a privately held company.

The Group currently operates through three business units (“BU”): the Cardiovascular BU, composed primarily of the BioMatrix™ family of drug-eluting stents and stent technologies such as BA9; the Cardiac Diagnostic BU, including Spectrum Dynamics products that offer advanced medical imaging and clinical solutions to help interventional cardiologists determine the most appropriate treatment for patients; and the Critical Care Products BU.

The Group has operations worldwide and is headquartered in Singapore.

For more information, please visit

Source: Biosensors International Group, Ltd.

Written by asiafreshnews

May 16, 2016 at 3:14 pm

Posted in Uncategorized

OurCrowd Taps nanorep to Provide Digital Self-Service for New Mobile App

leave a comment »

JERUSALEM /PRNewswire/ — OurCrowd, a leading equity crowdfunding platform, announced they will be utilizing nanorep’s digital experience technology for their new mobile application. The new app was launched at Finovate 2016 in San Jose, CA and is devoted to OurCrowd’s growing investor community.

The new mobile app is set to offer a full range of features with enhanced communication & sharing capabilities. nanorep, a leader in digital self-service solutions, was chosen to improve knowledge delivery and strengthen the quality of information in the user experience. OurCrowd was particularly drawn to nanorep’s Mobile SDK, which has been integrated within the app to provide their investor community accurate, context relevant information regarding portfolio companies and investment opportunities.

“Nanorep was the natural fit for OurCrowd when deciding who to integrate our new investor app with,” said OurCrowd’s Chief Product Officer, Shai Ben Tovim.  “Their advanced customer experience technology complimented some of the app’s key features, which include innovative social investing tools that allow investors to improve access to key investment information and to make more informed investment decisions.”

The app’s Automated Investment Assistant, which has been integrated with nanorep’s state-of-the-art service bot, has been designed to further help investors, to provide answers to investor queries, and build investor confidence. The service bot, when prompted, will tap into OurCrowd’s knowledge base to deliver reliable information to investors.

The integration of nanorep gives OurCrowd heightened visibility to the investor experience, with cutting-edge Voice of the Customer technology. According to nanorep CEO Eli Campo, “The implementation of nanorep into the mobile app will provide OurCrowd with unparalleled visibility of investor questions, enabling them to monitor and respond to investor information gaps with precision, in real-time.”

About OurCrowd:

OurCrowd is a leading equity crowdfunding platform for investors from around the world to invest in global startups. Managed by a team of seasoned investment professionals and led by serial entrepreneur Jon Medved, OurCrowd vets and selects opportunities, invests its own capital, and brings companies to its accredited membership of global investors.  OurCrowd provides post-investment support to its portfolio companies, assigning industry experts as mentors and in some cases takes board seats.  OurCrowd has raised over $220M for its 100 portfolio companies, generating six exits in three years. The OurCrowd community of 12,000+ investors from over 110 countries, mentors and partners is comprised of a diverse makeup of backgrounds, professions, locations, and investing experience. Post-investment, OurCrowd provides support to its portfolio companies, assigning industry experts as mentors and taking board seats, and invites its membership to participate in crowdbuilding companies.  To complete membership on OurCrowd as an accredited investor, visit and click Join. To download the OurCrowd app:

About nanorep:

nanorep provides a convenient, digitally intuitive, end-to-end solution for customer service, making digital service your customers’ preferred option. In addition to website, mobile, and CRM deployments, nanorep can integrate with popular messaging platforms, creating seamless customer experiences across every touch point in the digital journey. The simple and easy to use interface enables effortless engagements for customers and offers step-by-step guidance at the click of a button. Using patented NLP and Contextual-Answers™ technology, the system recognizes user intent and immediately delivers precise knowledge using information derived from a company’s knowledge base and CRM. In the event that additional support is required, smart-channeling capabilities enable the routing of customers to the most relevant assistance channel. nanorep also offers state-of-the-art analytics and Voice of the Customer technology to provide businesses with unparalleled visibility of the customer journey. Deployment and system integrations can be completed in a matter of weeks, offering greater business agility and rapid Time-to-Value. For more information about the company, please visit nanorep’s website:

Press contact:


Leah Stern
OurCrowd Director of Communications
+44.7470.196.826 / +1.877.848.0964 ext. 2

nanorep Technologies Ltd.

Yifat Mor
VP Marketing

Source: nanorep
Related Links:

Written by asiafreshnews

May 16, 2016 at 3:07 pm

Posted in Uncategorized

Didi Chuxing Announces Progress in Current Fundraising Round

leave a comment »

-Receives USD$1 billion strategic investment from Apple

BEIJING/PRNewswire/ — Didi Chuxing (“DiDi” or “the Company”), the world’s leading one-stop mobile transportation platform, announced today important progress in its latest fundraising round.  Among a group of prestigious Chinese and international institutions, Apple has invested USD$1 billion in DiDi, creating the single largest investment the Company has ever received.

Didi Chuxing factsheet
Didi Chuxing factsheet

Through this investment, Apple becomes a strategic investor of DiDi, and joins Tencent, Alibaba and other key supporters to help further DiDi’s mission of building a data-driven rideshare platform to serve hundreds of millions of Chinese drivers and passengers.

Cheng Wei, founder and CEO of DiDi, said, “The endorsement from Apple is an enormous encouragement and inspiration for our four-year-old company. DiDi will work hard with our drivers, riders and global partners, to make available to every citizen flexible and reliable mobility choices, and help cities solve transportation, environmental and employment challenges.”

“DiDi exemplifies the innovation taking place in the iOS developer community in China,” said Tim Cook, Apple’s CEO. “We are extremely impressed by the business they’ve built and their excellent leadership team, and we look forward to supporting them as they grow.”

Building on its data mining and analysis capabilities, DiDi now completes over 11 million rides a day on its platform, serving close to 300 million users across over 400 Chinese cities with a diverse range of mobile technology-based transportation options. DiDi works with over 14 million Chinese car-owners and drivers, holding over 87% market share in private car-hailing and over 99% market share in taxi-hailing.[1]


“Focus Report on Private-Car Hailing in China 2015”, China National Network Information Center

Didi Chuxing Media Enquiries

Mainland China

Brunswick Group
+86 (10) 5960 8600

Hong Kong

Brunswick Group
+852 3512 5000

United States

Sard Verbinnen & Co
+1 415 618 8750

Photo –

Source: Didi Chuxing

Written by asiafreshnews

May 16, 2016 at 2:50 pm

Posted in Uncategorized

Now Available from RS Components, Phoenix SKEDD Direct Wire-to-board Connectors Allow Easy Hand Assembly

leave a comment »

-New solderless connectors eliminate PCB headers, reduce component count

HONG KONG /PRNewswire/ — RS Components (RS), the trading brand of Electrocomponents plc (LSE:ECM), the global distributor for engineers, is delivering a new concept in PCB connection technology with the introduction of the SKEDD SDC 2,5 series of solderless direct wire-to-board connectors from Phoenix Contact.

Phoenix SKEDD direct wire-to-board connector
Phoenix SKEDD direct wire-to-board connector


Phoenix SKEDD direct wire-to-board connector
Phoenix SKEDD direct wire-to-board connector


SKEDD technology from Wurth Elektronik, and further developed by Phoenix, uses push-in spring contacts manufactured to fit PCB hole geometries perfectly. No soldering or press fitting is needed. Wires and cables can be plugged directly into a PCB without the need for a board-mounted header, eliminating an entire connection level and reducing component count. Wire-to-board connections can be made lighter and lower profile, supporting device miniaturisation. Compared to conventional header-and-socket configurations, SKEDD allows greater flexibility in positioning connectors and can reduce process time, cost, and the risk of manufacturing errors. SKEDD technology was named for its simple tool-free hand assembly: SKEDD translates as it’s done in Swedish.

The Phoenix Contact SDC 2,5 range incorporates SKEDD technology in a series of wire-to-board connectors with from 1 to 16 tin plated contacts at 5 mm pitch. Nominal cross-section is 2.5 mm2, nominal current is 12 A, and rated voltage (III/2) is 320 V. Assembly is intuitive thanks to a colour differentiated actuation lever, and connection quality is unaffected by multiple insertions and extractions.

A secure locking mechanism between the connector housing and the PCB ensures a robust, reliable, vibration-resistant mechanical connection, even under harsh environmental conditions. An integrated test option provides for quick and easy connector testing.

Sharon Milne, Global Account Manager at RS, commented: “The strong business relationship between RS and Phoenix Contact ensures that customers have the advantage of fast, efficient delivery, direct from stock, onPhoenix products based on the new SKEDD connection technology.”

“As a key strategic distribution partner, we rely on RS Components to help us bring our latest innovations to the marketplace, offering our customers fast, worldwide access to our newest products,” said Benedikt Hagemann, Corporate Channel Partner Management at Phoenix Contact.

About RS Components

RS Components and Allied Electronics are the trading brands of Electrocomponents plc, the global distributor for engineers. With operations in 32 countries, we offer more than 500,000 products through the internet, catalogues and at trade counters to over one million customers, shipping around 44,000 parcels a day. Our products, sourced from 2,500 leading suppliers, include electronic components, electrical, automation and control, and test and measurement equipment, and engineering tools and consumables.

Electrocomponents is listed on the London Stock Exchange and in the last financial year ended 31 March 2015had revenues of GBP1.27bn.

For more information, please visit the website at

Editorial Contacts:                                                            

Vivian Zee
Public Relations & Advertising Manager
RS Components

Matthew Keefe
Customer Marketing Manager
RS Components

Further information is available via these links:

Twitter: @RSComponents; @alliedelec; @designsparkRS

RS Components on Linkedin

Relevant Links:

Electrocomponents plc

RS Components


Photo –
Photo –
Logo –

Source: RS Components

Related stocks: LSE:ECM OTC-PINK:EENEY

Written by asiafreshnews

May 16, 2016 at 2:45 pm

Posted in Uncategorized

EndoStim Secures $25 Million in Funding to Expand Commercialization Efforts and Conduct a Pivotal U.S. Clinical Trial

leave a comment »

NIJMEGEN, The Netherlands and ST. LOUIS /PRNewswire/ — EndoStim, Inc., a medical device company that has developed neurostimulation therapy for gastroesophageal reflux disease (GERD), today announced it has completed a Series D financing round of $25 million. Endeavour Vision, an internationally recognized investor in healthcare and technology companies, led the round, with participation from existing investors, led by Santé Ventures. New investors Wellington Partners and Gimv completed the syndicate.

Stimulating reflux care. Transforming lives.
Stimulating reflux care. Transforming lives.



EndoStim LES Stimulation Therapy for GERD
EndoStim LES Stimulation Therapy for GERD

Photo –
Logo –

“Hundreds of millions of patients worldwide suffer from GERD, and many are not optimally treated with long-term proton pump inhibitor medication,” said Doug French, managing director of Santé Ventures and chairman of EndoStim’s Board of Directors. “We believe EndoStim is perfectly positioned to address the therapy gap that exists for patients with severe reflux, which is why we are very excited to welcome such an experienced group of new investors to the EndoStim team.”

EndoStim has developed a unique, minimally-invasive implantable device designed to provide long-term reflux control by restoring normal esophageal function through low-energy personalized neurostimulation. The therapy directly targets the patient’s weak or dysfunctional lower esophageal sphincter (LES) muscle between the stomach and the esophagus, often the underlying cause of reflux. Two long-term clinical trials and an ongoing international patient registry continue to demonstrate successful control of abnormal acid in the esophagus and significant improvement in patient quality of life through up to four years of follow-up with an excellent safety profile.

The Series D financing will support expanded commercialization efforts for EndoStim’s minimally-invasive GERD therapy outside the United States; a randomized sham-controlled pivotal trial in the United States; and the development of next generation devices.

“Endeavour Vision is proud to partner with EndoStim, which has created a truly revolutionary, minimally-invasive therapy that provides long-term control of esophageal acid exposure, while avoiding the risk of side effects that is common with traditional anti-reflux surgery,” said Alexander Schmitz, who recently joined the EndoStim board representing Endeavour Vision. “We are confident that EndoStim will ultimately become a standard of care in GERD treatment in the U.S. and worldwide.”

About EndoStim

EndoStim is a medical device company based in St. Louis, Missouri, and Nijmegen, The Netherlands, developing and commercializing a revolutionary treatment for GERD. The EndoStim system is CE Marked for patients with gastro-esophageal reflux disease with symptom duration of six months or longer, and is available in a number of countries throughout Europe, Latin America, and Asia Pacific. The EndoStim system is not approved for sale in the US and is limited by US federal law to investigational use only. For more information, visit

About Endeavour Vision

Endeavour Vision is an internationally recognized investor in healthcare and technology companies. The team, which partners successful investment professionals with world-class industry veterans, has executed more than 65 investments within its focus verticals. With the recent closing of the Endeavour Medtech Growth Fund, Endeavour Vision is advising one of the largest funds dedicated to helping medical technology companies in Europe and the US to accelerate their global growth and market leadership. For more information, visit

About Santé Ventures

Santé Ventures is a life sciences venture capital firm that invests exclusively in early-stage companies developing innovative new medical technologies or healthcare delivery models. The firm was founded in 2006 and has $280 million in capital under management in two funds. For more information, visit

About Gimv

Gimv is a European investment company with over three decades experience in private equity and venture capital. The company is listed on Euronext Brussels. Gimv currently manages around 1.8 billion EUR (including co-investment partnerships) of investments in about 50 portfolio companies.

As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv’s four investment platforms are: Connected Consumer, Health & Care, Smart Industries and Sustainable Cities. Each of these platforms works with a skilled and dedicated team across Gimv’s home markets of the Benelux, France andGermany and can count on an extended international network of experts.  More information on Gimv can be found on

About Wellington Partners

Wellington Partners is among the most successful pan-European Venture Capital firms. With more than € 800 million under management and offices in Munich, London and Zurich, Wellington Partners invests in start-up companies throughout Europe that have the potential to become global leaders in the areas of digital media, resource efficiency and life sciences. Since 1998, Wellington Partners has invested in more than 100 companies, including publicly listed firms like Actelion, Evolva, Genticel, Oxford Immunotec, Supersonic Imagine, Wavelight (acquired by Alcon) and Xing as well as privately held companies like AyoxxA, Definiens (acquired by Medimmune), Grandis (acquired by Novartis), G-Therapeutics, ImevaXx, immatics, Immobilienscout24 (acquired by Deutsche Telekom), invendo medical, MPM Medical, MTM Laboratories (acquired by Roche), NEUWAY Pharma, Oxagen/Atopix, Quanta, Rigontec, Sapiens (acquired by Medtronic), Sensimed, Symetis, Spotify and Themis. For further information, please visit

For more information, please contact:
Eileen Ke

Photo –
Photo –

Source: EndoStim
Related Links:

Written by asiafreshnews

May 16, 2016 at 2:39 pm

Posted in Uncategorized

Weyerhaeuser/IP deal highlights global trends in fluff pulp market

leave a comment »

-Rationalization possible as new capacity comes online

BOSTON /PRNewswire/ — On May 2, Weyerhaeuser announced the sale of all of its fluff pulp assets to International Paper (IP) for $2.2 billion. These two firms account for 39% of the global market for fluff pulp, which is used in diapers and other absorbent hygiene products. The deal may result in asset spin-offs to satisfy regulators. Along with other capacity expansion projects, this hints at further potential rationalization in the fluff pulp space. This and other trends are explored in the Outlook for the World Fluff Pulp Market, a new report from RISI – the leading source of business intelligence for the global forest products industry.

“The expected increase in fluff pulp manufacturing capacity will reduce operating rates for the industry. New plants and conversions could lead to an oversupply in the global market,” said Ben Sirois, RISI economist and lead author of the Outlook.

The study explores drivers of disruption among fluff pulp suppliers, including:

  • Potential for further M&A, in the wake of the recent Weyco/IP deal
  • Possible over-capacity, as new plants come online faster than the market is growing
  • Development of fluff pulp made from hardwood, to potentially challenge the dominance of US southern softwood in fluff pulp production

The study also includes supply, demand, cost, and pricing history and forecasts for the entire world fluff pulp sector.

The full Outlook for the World Fluff Pulp Market will be released in coming weeks. A preliminary forecast is available for those who pre-order the study today. To get access to the report, visit

Companies with historical fluff pulp data included in the study:

Current Fluff Pulp Producers:
Arauco, Domtar, Fujian Tengrongda, Georgia-Pacific, International Paper, Klabin, Rayonier, Resolute Forest Products, SCA, Stora, Suzano, UPM, WestRock, Weyerhaeuser

Past Fluff Pulp Producers:
Celulosa Cambara, CHH Pulp & Paper, CMPC, Kimberly-Clark, Korsnas, Lwarcel, M-real, Paper Excellence, Skogall, Tembec

About RISI (
RISI is the leading information provider for the global forest products industry. The company works with clients in the pulp and paper, packaging, wood products, timber, biomass, tissue and nonwovens industries to help them make better decisions. Headquartered in Boston, MA, RISI operates additional offices throughout North and South America, Europe and Asia.

For Press Inquiries, please contact:
Alan Petrillo
Communications Associate
O: +1.781.778.7592

Logo –

Source: RISI
Related Links:

Written by asiafreshnews

May 16, 2016 at 2:36 pm

Posted in Uncategorized

4 Summer Marketing Strategies that Boost Business

leave a comment »

NEW YORK /PRNewswire/ — While summer is one of the most enjoyable times of the year, it shouldn’t be a time that your small business suffers. There are plenty of seasonal marketing opportunities that you can leverage, and in the latest article posted to PR Newswire’s Small Business PR Toolkit, contributing author Jim Higgins offers four simple ways to boost your sales this summer:

Logo –

  • Summer referral program.  Target your current customers by making them a limited-time offer. Offer an additional incentive if they refer new business and reward them accordingly.
  • Host a free “Lunch & Learn” series. Single out a unique expertise of real value that you can share with your customers and organize this information into a series of 30-minute webinar sessions that can be delivered on a weekly basis.
  • Run a “We Miss You” campaign. Identify past customers that you haven’t communicated with during the past three months and target these existing customers with a “We miss you, we want you back” message. Consider also including a limited-time offer for these special customers.

To read Higgins’ remaining summer marketing strategy, visit his article here:

PR Newswire’s Small Business PR Toolkit is a comprehensive resource that provides small businesses and entrepreneurs the tools to develop an affordable public relations and marketing plan that helps generate interest from potential customers, engage with key audiences and grow their businesses. The toolkit features relevant content such as informative white papers, interactive webinars and how-to articles and premium access to educational resources, as well as the opportunity to take advantage of special offers designed specifically for small businesses. To request information on how PR Newswire can help your small business, click here. You can receive updates on new Small Business PR Toolkit content by following @prnsmallbiz on Twitter.

About PR Newswire                       

PR Newswire ( is the premier global provider of multimedia platforms that enable marketers, corporate communicators, sustainability officers, public affairs and investor relations officers to leverage content to engage with all their key audiences. Having pioneered the commercial news distribution industry over 60 years ago, PR Newswire today provides end-to-end solutions to produce, optimize and target content — from rich media to online video to multimedia — and then distribute content and measure results across traditional, digital, mobile and social channels. Combining the world’s largest multi-channel, multi-cultural content distribution and optimization network with comprehensive workflow tools and platforms, PR Newswire enables the world’s enterprises to engage opportunity everywhere it exists. PR Newswire serves tens of thousands of clients from offices in the Americas, Europe, Middle East, Africa and the Asia-Pacific region, and is a UBM plc company.

Amanda Eldridge
Director, Strategic Channels

Source: PR Newswire Association LLC

Related stocks: LSE:UBM OTC-PINK:UBMPY

Written by asiafreshnews

May 16, 2016 at 2:26 pm

Posted in Uncategorized